Value-based pricing and the evolving role of the medical affairs professional

As healthcare moves to an outcomes-based model, pharmaceutical companies are starting to accept the idea of value-based contracts, which tie reimbursement for individual therapies to patient outcomes. The practice has quietly been in place, in niche areas such as specialty...